Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07197775

Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)

This registry is designed to collect long-term data and support ongoing post-market surveillance of real-world data for the Endogenex System.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia

Loading trial locations.

About this study

This is an observational registry that is designed to facilitate long-term patient follow-up for up to 5 years after an Endogenex procedure. It is structured to enable systematic longitudinal data collection on the safety and long-term clinical outcomes associated with the Endogenex System.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Type 2 diabetes
  • Have been treated with the Endogenex System
  • Consented to participate in the Endogenex PULSE Registry

Exclusion criteria

  • Unwilling or unable to attend study visits
  • Unwilling or unable to provide medical records to study sites

Treatment and study plan

Primary outcomes

  1. Incidence of adverse events

    Time frame: Through 5 years

    Incidence of device-related and/or procedure-related adverse events

Sponsors and collaborators

Lead sponsor

Endogenex, Inc.

Industry

Registry information

Official study title

Endogenex PULSE Registry

Important dates

Study start
2026
Primary completion
2032
Study completion
2032
First posted
Sep 29, 2025
Registry last updated
Jul 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.